Harmony Biosciences Holdings, Inc.
- Stock
- Ticker HRMY
- Nasdaq
Performance, volatility and drawdowns of Harmony Biosciences Holdings, Inc. since 08/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $7,859. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −68.5% in 10/2023, measured from the peak in 12/2022. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 201 | 185 | 200 | 239 | 244 | 215 | 261 | 269 |
| Gross profit | 147 | 153 | 162 | 180 | 175 | 171 | 198 | 188 |
| Operating income | 56 | 56 | 48 | 65 | 39 | 37 | 89 | 54 |
| EBITDA | 56 | 56 | 48 | 65 | – | 37 | 89 | 54 |
| Net income | 49 | 46 | 40 | 51 | 22 | 32 | 75 | 48 |
| Earnings per share | 0.85 | 0.78 | 0.68 | 0.87 | 0.39 | 0.55 | 1.28 | 0.81 |
| Balance sheet | ||||||||
| Total assets | 999 | 1,056 | 1,108 | 1,208 | 1,272 | 1,272 | 1,373 | 1,478 |
| Liabilities | 340 | 335 | 335 | 373 | 401 | 361 | 374 | 406 |
| Equity | 659 | 721 | 773 | 835 | 870 | 910 | 999 | 1,072 |
| Cash | 453 | 489 | 546 | 647 | 753 | 589 | 550 | 647 |
| Long-term debt | 163 | 158 | 153 | 149 | 144 | 139 | 134 | 129 |
| Cash flow | ||||||||
| Operating cash flow | 76 | 34 | 79 | 109 | 126 | 28 | 92 | 77 |
| Capital expenditure | -0.5 | -0.1 | 0.0 | -0.1 | -0.1 | – | – | – |
| Free cash flow | 75 | 34 | 79 | 109 | 126 | 28 | 92 | 77 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2022 at +29.2%, weakest 2023 at −41.4%. 4 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | $0.81 |
| 4 Aug 2026 | $1.28 |
| 7 May 2026 | $0.55 |
| 24 Feb 2026 | $0.39 |
| 4 Nov 2025 | $0.87 |
| 5 Aug 2025 | $0.68 |
| 6 May 2025 | $0.78 |
| 25 Feb 2025 | $0.85 |
| 29 Oct 2024 | $0.79 |
| 6 Aug 2024 | $0.20 |
| 30 Apr 2024 | $0.67 |
| 22 Feb 2024 | $0.45 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.7bn
- Market cap in trading currency
- $1.91bn
- Enterprise value
- $1.29bn
- P/E
- 10.8
- P/S
- 1.93
- P/B
- 1.78
- EV/Sales
- 1.31
- EV/EBITDA
- –
- Earnings yield
- 9.3%
- FCF yield
- 16.9%
Results (last four quarters)
- Revenue
- $989m
- Gross profit
- $732m
- EBITDA
- –
- Net income
- $179m
- Earnings per share
- $3.03
- Revenue per share
- $16.85
- Revenue growth
- +12.3%
- Earnings growth
- −5.2%
Profitability
- Gross margin
- 74.0%
- Operating margin
- 22.2%
- Net margin
- 18.1%
- Return on equity
- 18.7%
- Return on assets
- 12.1%
Balance sheet and cash flow
- Cash
- $771m
- Cash per share
- $13.13
- Financial debt
- $149m
- Debt/equity %
- 14
- Current ratio
- 3.44
- Book value per share
- $18.26
- Operating cash flow
- $323m
- Free cash flow
- $323m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 58.7m
- Volume
- 582,620
- Avg. volume 3 months
- 1.01m
- Relative volume
- 0.6
Price and technicals
- Price
- $32.59
- 1 day
- −1.2%
- 52-week high
- $42.86
- 52-week low
- $26.54
- Distance to 52-week high
- −24.0%
- Distance to 52-week low
- +22.8%
- Distance to 50-day line
- −13.7%
- Distance to 200-day line
- −5.4%
- RSI (14)
- 32
- Volatility 1M
- 40.3%
Performance
- 1 week
- −3.5%
- 1 month
- −9.5%
- 3 months
- −15.4%
- 6 months
- +8.1%
- YTD
- −12.9%
- 1 year
- −2.2%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has HRMY performed since 08/2020?
$10,000 grew to $8,806 by 20 Nov 2026, which is −2.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is HRMY?
Volatility was 43.8% per year, measured on monthly returns. The largest decline from a peak was −68.5%, with the low in 10/2023.
How does HRMY compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.4% per year at 15.1% volatility, HRMY returned −2.0% at 43.8%. The correlation of monthly returns was 0.30; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.